Integrating Insulin Resistance Remission into
Ayurvedic Practice
Awaken Radiant Health For 40%–50% of the Western World
The Silent Pathway: From Root Cause to Manifest Disease
The most visible and concrete outcomes — the conditions people present with — sit at the top. The causal chain descends to its most subtle root cause at the bottom.
The Significance Of Insulin Resistance
The evidence is very clear that insulin resistance is the root cause of a vast range of issues, because it acts on every cell in the body all the time. What this means is that addressing that one issue can lead to other interventions being more effective, including Ayurvedic remedies in routine or supplements.
"Insulin resistance is the root cause of many heart conditions."
Dr. Pradip Jamnadas MD, FACC · Yale-trained Interventional Cardiologist
"Insulin resistance is not a benign condition. It is the tip of a major iceberg in health."
Dr. William Davis MD · Preventive Cardiologist, Author of Wheat Belly
"IR is the cornerstone of a unifying theory of chronic disease."
Dr. Jason Fung MD · Co-founder, Intensive Dietary Management Programme, Toronto
Pulse diagnosis is highly refined — it can detect that something is out of balance. But it cannot reach below the level of biochemistry to identify why. The diagram below shows both pathways rising from the same root: the imbalance the pulse detects on the left, and the actionable solution on the right — both with the same origin.
If a pulse reading detects an imbalance that would typically be addressed with one or a few herbal supplements, it is worth asking: could insulin resistance be the root cause? If so, reversing insulin resistance through a no-grains diet with intermittent fasting — tailored to the client's individual mind-body constitution — may resolve the detected imbalance at its source.
A fasting and dietary protocol suited to the client's constitutional type is applicable to the vast majority of clients, and may be the most powerful single intervention available.
The proven approach to reversing insulin resistance centres on eliminating grains. This matters not only because grains are high in carbohydrates and drive rapid insulin spikes — but because of a second, equally significant mechanism: grains trigger the release of zonulin, a protein that disrupts tight junctions in the gut wall, causing intestinal permeability (leaky gut). This allows lipopolysaccharides and incompletely digested food fragments to enter the bloodstream, driving systemic inflammation and contributing to arterial plaque formation — compounding the cardiovascular risk that insulin resistance already creates.
The Integration: Ayurveda & Metabolic Science Measurement
Two frameworks — converge toward one integrated outcome.
Ayurveda has long understood that each person carries a constitutional signature — a unique expression of Vata, Pitta, or Kapha — that shapes their vulnerabilities, their disease patterns, and the interventions most likely to restore balance.
This is a profound and clinically useful framework. But there is a gap.
Pulse diagnosis, the primary investigative tool in Ayurvedic assessment, cannot detect insulin resistance. Not because it is insufficiently refined — but because insulin resistance is a biochemical state, measurable only through blood. Specifically, through a HOMA-IR calculation derived from fasting insulin and fasting glucose levels, producing a score that ranges from below 1.0 in metabolically healthy individuals to above 2.9 in those with significant resistance. Critically, a person can carry elevated insulin resistance for five to twenty years before any diagnosable disease becomes apparent. They may present with vague fatigue, weight gain, brain fog, or mood disturbance — findings that map easily onto a Vata, Pitta, or Kapha imbalance — while the underlying metabolic driver goes entirely undetected.
This is a significant clinical blind spot. When pulse diagnosis identifies an imbalance, it is detecting something real — a disruption that is genuine and addressable. But in a client who carries undetected insulin resistance, that imbalance may itself be a downstream expression of the biochemical dysfunction. Addressing it with herbal supplements or constitutional adjustments may bring partial relief, yet the root cause continues to operate silently beneath the level that pulse diagnosis can reach. If insulin resistance were identified and reversed first, many of the imbalances detected by pulse diagnosis might resolve without needing to be the primary focus of treatment at all.
This matters because current estimates suggest that between 40 and 60% of Western adults have some degree of insulin resistance, varying by country and diagnostic threshold. It is the most prevalent undiagnosed chronic condition in the Western world, and it is now well established as the primary upstream driver of type 2 diabetes, hypertension, fatty liver disease, cardiovascular disease, many cancers, Alzheimer's disease, ADHD, irritable bowel syndrome (IBS), arthritis, OCD, and more. These are not unrelated diseases — they are expressions of a single underlying metabolic dysfunction; issues that conventional medicine typically addresses symptom by symptom, most often with pharmaceutical intervention that manages the downstream manifestation while leaving the root cause entirely untouched.
In the UK, up to 55% of adults — an estimated 30 million people — are mostly living with undetected insulin resistance.
The reason for this is just structural — in other words, inbuilt in the treatment paradigm. Dietary and lifestyle interventions — specifically intermittent fasting and a very low carbohydrate diet eliminating grains and refined sugars — have been demonstrated in peer-reviewed research to reverse insulin resistance¹, and with it to resolve or significantly reduce many of the conditions listed above. But these interventions are not patentable. They cannot be prescribed in a ten-minute appointment. They require sustained coaching, accountability, and individualised adjustment over months. Healthcare systems are not designed to deliver this, and most practitioners are not trained to provide it.
This is where the Ayurvedic practitioner stands in a uniquely powerful position — and where a significant integration opportunity has, until now, been missed.
The Ayurvedic understanding of constitutional types does not simply categorise people; it predicts their specific metabolic vulnerabilities and points toward the dietary and lifestyle adjustments most likely to work for that individual. A Kapha-dominant person developing insulin resistance will present differently and respond differently to intervention than a Vata-dominant person with the same HOMA-IR score. This is precisely the kind of nuance that a one-size-fits-all nutritional protocol cannot provide — and it is the kind of nuance that the Ayurvedic model is uniquely equipped to offer.
What has not yet happened is the formal integration of insulin resistance as a recognised diagnostic baseline within Ayurvedic practice. Pulse diagnosis should be complemented, not replaced, with a HOMA-IR test as a near-universal intake assessment for new clients. This single addition would allow practitioners to identify the silent metabolic driver that underlies the majority of the chronic conditions they are already treating — and to apply the full depth of Ayurvedic constitutional understanding to reversing it.
Insulin Resistance & the Seven Dhatus
A Convergence of Ancient and Modern Understanding
In Ayurveda, every disease begins with a weakening of Agni — the metabolic fire operating at every level, from the gut (Jatharagni) to each tissue (Dhatvagni). When Agni is chronically disturbed, improperly transformed material produces Ama — a sticky, toxic residue that accumulates in the channels (Srotas), blocks cellular communication, and becomes the seed of systemic disease. Insulin resistance, in this framework, is fundamentally an Agni disorder — a failure of Dhatvagni spreading progressively through the Dhatu sequence.
The cell's inability to receive and process glucose is a failure of tissue-level metabolic fire spreading progressively through the Dhatu chain. Ama introduced early in the chain corrupts everything downstream — a principle that maps precisely onto the modern understanding of how insulin resistance propagates through organ systems over years and decades.
This is the first tissue nourished after digestion. In a healthy state, Rasa carries pure nourishment and maintains Vyadhikshamatva (immune resilience) throughout the body. In insulin resistance, impaired Jatharagni produces Ama that immediately enters Rasa — mapping precisely to the chronic low-grade inflammatory signalling seen in elevated cytokines (TNF-alpha, IL-6), dysregulated adipokines, and disordered blood glucose that circulate systemically before overt disease appears. Rasa becomes turbid and Ama-laden, compromising its ability to nourish all downstream tissues.
Ama in Rakta manifests as oxidative stress, endothelial inflammation, and dyslipidaemia — the exact processes modern research links to early cardiovascular risk in insulin resistance. The blood vessels become sticky and reactive. The Rakta Srotas become coated with Ama, impairing their ability to carry Prana and clear metabolic waste. This is the beginning of atherosclerosis — Rakta Dushti.
Skeletal muscle is the primary site of glucose disposal in the body. In insulin resistance, muscle cells lose their responsiveness to insulin — Mamsa Dhatvagni is suppressed. The muscle cannot properly receive or metabolise glucose, contributing to rising blood sugar and forcing the pancreas to overproduce insulin. Ama blocks the Mamsa Srotas, preventing proper nourishment and the functional integrity of the tissue.
Meda Dhatu's own Agni (Meda Dhatvagni) becomes severely impaired. Adipose tissue expands abnormally — especially visceral fat — and becomes infiltrated by inflammatory M1 macrophages. It begins secreting pro-inflammatory adipokines (leptin, resistin, chemerin) rather than anti-inflammatory ones (adiponectin), and free fatty acids flood the bloodstream. This is Meda Vriddhi — excess and pathological Meda — combined with deep Ama accumulation. Since Meda nourishes the three deeper, more subtle Dhatus, its corruption now sends Ama-laden nutrition downward into them.
Chronic inflammation and metabolic imbalance from corrupted Meda now begin affecting bone density and joint integrity. Modern research confirms that insulin resistance is associated with increased fracture risk, inflammatory arthritis, and degraded bone metabolism. The Asthi Srotas receive improperly formed Meda nutrition, and Asthi Dhatvagni cannot build healthy bone tissue — producing instead fragile, inflamed skeletal structures.
This is where the immune connection becomes most profound — modern science and Ayurveda converge dramatically here. Bone marrow is where immune cells are born. When Majja Dhatu receives Ama-corrupted nourishment, immune cell precursors (monocytes, lymphocytes, NK cells) develop with intrinsic dysfunction, emerging already skewed toward inflammatory, poorly regulated behaviour. This maps directly to research showing T cells, B cells, macrophages, and NK cells all shifting toward pro-inflammatory states. At the nervous system level, the neurological complications of long-term insulin resistance — neuropathy, cognitive decline, the Alzheimer's connection — represent Ama in Majja Dhatu.
The seventh and most refined Dhatu represents the distilled essence of all previous transformations. From Shukra/Artava comes Ojas — the master substance of immunity and vitality in Ayurveda; what modern science might call the immune system's integrated capacity to respond appropriately and maintain tolerance. When all six preceding Dhatus are corrupted, Ojas production fails — manifesting as loss of Vyadhikshamatva, autoimmune dysregulation, cancer vulnerability, and profound fatigue. This is precisely what research describes: immune cells that are chronically inflamed, unable to mount proper responses, and unable to maintain regulatory balance.
A core Ayurvedic principle: as Ama increases, Ojas decreases. The research confirms this with striking precision.
| Ama Accumulation | Ojas Depletion |
|---|---|
| Chronic low-grade inflammation | Weakened immune resilience |
| Cytokine excess (TNF-alpha, IL-6) | Loss of immune regulation |
| Macrophage M1 polarisation | Failure of immune tolerance |
| Blocked Srotas | Impaired cellular communication |
| Progressive organ damage | Vulnerability to cancer, infection & autoimmunity |
What Ayurveda offers that modern medicine is only recently catching up to is the understanding that this is a whole-system, sequential, progressive corruption — not a collection of separate diseases. Type 2 diabetes, heart disease, Alzheimer's, cancer, and immune failure are not independent conditions; they are the downstream expressions of the same upstream impairment of Agni and the same accumulation of Ama moving through the Dhatu chain.
The modern research essentially confirms what Ayurveda mapped thousands of years ago: treat the Agni, clear the Ama, and protect the Ojas — before the corruption reaches the deeper tissues where reversal becomes far more difficult.
This systematic review and meta-analysis of 10 randomised controlled trials involving 701 adults with metabolic syndrome found that intermittent fasting significantly reduced fasting blood glucose, insulin levels, HOMA-IR, and HbA1c — all primary markers of insulin resistance — with high-quality GRADE evidence for each outcome. HOMA-IR decreased by a standardised mean difference of −0.39. The authors conclude that intermittent fasting produces improvement in glycaemic control and insulin sensitivity comparable to pharmaceutical insulin sensitisers, but without the associated side effects.
This comprehensive review maps how the insulin receptor is expressed across all major immune cell types and shapes their behaviour. It documents how chronic hyperinsulinaemia drives immune cells to become insulin-resistant themselves, undermining both protective immunity and immune tolerance. It specifically connects these mechanisms to type 2 diabetes, cancer susceptibility, and increased vulnerability to infections including COVID-19.
This study details how insulin resistance shifts macrophages, T cells, B cells, and NK cells into chronic pro-inflammatory states. It examines how dysregulated adipokines like leptin and resistin drive immune polarisation, and how the resulting inflammation creates a self-reinforcing cycle that drives beta-cell destruction. It argues that addressing immune dysfunction — not just blood sugar — is essential for comprehensive diabetes management.
Researchers analysed 43 immune activation markers in 150 volunteers and identified a distinct immune profile strongly correlated with insulin resistance and metabolic syndrome. This profile was characterised by CD4+ T cell ageing, B cell activation, and elevated inflammatory markers like TNF-alpha. The study suggests this immune signature could serve as an early screening tool to identify people at risk for metabolic disease before full diabetes develops.
This paper explores how insulin resistance in the context of obesity accelerates immune ageing (immunosenescence), causing immune cells to prematurely lose their protective capacity. Senescent immune cells secrete pro-inflammatory compounds that damage surrounding tissues, creating a vicious cycle linked to cardiovascular disease, Alzheimer's, and autoimmune conditions.